<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02108990</url>
  </required_header>
  <id_info>
    <org_study_id>2012HO294</org_study_id>
    <secondary_id>KL2RR025754-04</secondary_id>
    <nct_id>NCT02108990</nct_id>
  </id_info>
  <brief_title>Acetaminophen and Social Processes</brief_title>
  <official_title>Acetaminophen and Social Pain in Borderline Personality Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Advancing Translational Science (NCATS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent research has identified heightened sensitivity to social rejection as a core feature&#xD;
      of BPD. Rejection sensitivity can trigger the aggressive, impulsive, and self-injurious&#xD;
      behaviors characteristic of the disorder.&#xD;
&#xD;
      Therefore targeting therapy towards the reduction of rejection sensitivity may improve the&#xD;
      low rates of effectiveness of current pharmacological and behavioral therapies. Therefore,&#xD;
      this proposal tests a theoretically-based pharmacological approach that specifically targets&#xD;
      the heightened sensitivity to rejection experienced by BPD patients.&#xD;
&#xD;
      In prior research with normal controls, it was shown that chronic treatment with the physical&#xD;
      pain-killer acetaminophen (e.g. Tylenol) reduced both neural responses to social rejection&#xD;
      (using fMRI) as well as self-reported feelings of rejection in a daily diary study.&#xD;
&#xD;
      It is the aim of this research project to determine if the over-the-counter analgesic,&#xD;
      acetaminophen (active ingredient in Tylenol), can reduce symptoms and behaviors in BPD&#xD;
      patients. The goal of this proposal is to use an open-label design to determine if&#xD;
      acetaminophen improves symptoms in BPD patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in symptom reports on the PAI-BOR at week 6</measure>
    <time_frame>Baseline, Week 6</time_frame>
    <description>Symptom reports on the PAI-BOR.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in symptom severity on the Zanarini Rating Scale for Borderline Personality Disorder</measure>
    <time_frame>Baseline, Week 6</time_frame>
    <description>Zanarini Rating Scale for Borderline Personality Disorder</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom Reports</measure>
    <time_frame>Baseline, weeks, 1,2,3,4,5,6 and 8.</time_frame>
    <description>Each week participants will be emailed a link to complete that will have three surveys.&#xD;
The Beck Depression Inventory&#xD;
The Beck Anxiety Inventory&#xD;
The Inventory of Interpersonal Problems (Aggression and Interpersonal Sensitivity Subscales).&#xD;
This weekly survey report will also be sent to the participants once after the completion of pharmacotherapy (at the two weeks post cessation treatment).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily Diary</measure>
    <time_frame>Daily for week 0,1,2, and 3</time_frame>
    <description>The importance of these measures will be to assess how rejected, aggressive, and social participants have been in order to determine if acetaminophen affects these proclivities. Participants will report on: hurt feelings, rejection, affect, aggressive feelings, impulsive behaviors, alcohol use, sleep, social interactions, perceived stress, self-esteem</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Borderline Personality Disorder</condition>
  <arm_group>
    <arm_group_label>Acetaminophen 1000mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acetaminophen 1000mg capsule orally three times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen 500mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>500mg Acetaminophen orally three times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <arm_group_label>Acetaminophen 1000mg</arm_group_label>
    <arm_group_label>Acetaminophen 500mg</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinical diagnosis of borderline personality disorder&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  if on psychiatric medication, must be on a stable dose&#xD;
&#xD;
          -  able to swallow tablets&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current, primary substance abuse, particularly alcoholism&#xD;
&#xD;
          -  current eating disorder&#xD;
&#xD;
          -  history or current psychotic disorder&#xD;
&#xD;
          -  suicidal ideation or behavior requiring imminent inpatient treatment&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  Participants whose medication has not been stable for more than 4 weeks&#xD;
&#xD;
          -  Impaired liver function (&gt; 1.25x the upper limit of the reference range)&#xD;
&#xD;
          -  Conditions that can affect immune system functioning.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baldwin M Way, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer S. Cheavens, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dewall CN, Macdonald G, Webster GD, Masten CL, Baumeister RF, Powell C, Combs D, Schurtz DR, Stillman TF, Tice DM, Eisenberger NI. Acetaminophen reduces social pain: behavioral and neural evidence. Psychol Sci. 2010 Jul;21(7):931-7. doi: 10.1177/0956797610374741. Epub 2010 Jun 14.</citation>
    <PMID>20548058</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>December 21, 2015</last_update_submitted>
  <last_update_submitted_qc>December 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Baldwin Way</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>borderline personality disorder</keyword>
  <keyword>rejection</keyword>
  <keyword>social pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Personality Disorders</mesh_term>
    <mesh_term>Borderline Personality Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

